{
    "nct_id": "NCT04417088",
    "official_title": "Assessment of Safety and Feasibility of Exablate Type 2 for Blood-Brain Barrier Disruption (BBBD) With Microbubble Resonators for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy",
    "inclusion_criteria": "* Must be between 18-80 years old\n* Histologically confirmed glioblastoma\n* Planned for Carboplatin monotherapy\n* Be willing and able to provided written informed consent/asent\n* Tumor progression after first line chemo radiation\n* Recovered to grade 0 or 1 or pre-treatment baseline from clinically significant toxic effects of prior therapy\n* Women of childbearing potential is confirmed not pregnant. Male and Female subjects utilize highly effective contraception\n* Able to communicate verbally\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Acute intracranial hemorrhage\n* Ferrous metallic implanted objects in the skull or brain\n* Prior toxicity with carboplatin chemotherapy\n* Women who are pregnant or breastfeeding\n* Cerebellar spinal cord or brain stem tumor\n* Known active Hepatitis B or Hepatitis C or HIV\n* Significant depression not adequately controlled\n* Has previously received anti-VEGF or anti-VEGF agents like Avastin\n* Cardiac disease or unstable hemodynamics\n* Severe hypertension\n* History of a bleeding disorder, coagulopathy or with a history of spontaneous tumor hemorrhage\n* Active drug or alcohol use disorder\n* Known sensitivity to gadolinium-based contrast agents\n* Known sensitivity or contraindications to ultrasound contrast agent or perflutren\n* Unable to undergo MRI or contraindications to MRI such as non-MRI compatible implanted devices\n* Difficulty lying supine and still or severe claustrophobia which cannot be managed with medication\n* Severely impaired renal function\n* Right to left or bi-directional cardiac shunt\n* Cranial or systemic infection requiring antibiotics\n* Known additional malignancy that is progression or require active treatment",
    "miscellaneous_criteria": ""
}